Source: Pharmaceutical Benefits Scheme (AU) Revision Year: 2018 Publisher: Pfizer Australia Pty Ltd, 38-42 Wharf Road, West Ryde NSW 2114, Toll Free Number: 1800 675 229, www.pfizer.com.au
LINCOCIN lincomycin – 600mg/2mL (as hydrochloride) injection vial.
| Pharmaceutical Form |
|---|
|
LINCOCIN Injection is a clear, colourless or almost colourless solution, practically free from particles. |
Lincomycin hydrochloride.
Each mL contains lincomycin hydrochloride equivalent to lincomycin base 300 mg;
Excipients with known effect: benzyl alcohol, 9.45 mg
For the full list of excipients, see section 6.1, List of Excipients.
| Active Ingredient | Description | |
|---|---|---|
| Lincomycin |
Lincomycin is an antibiotic produced by fermentation of Streptomyces lincolnensis. Lincomycin inhibits bacterial protein synthesis by binding to the 50S subunit of the bacterial ribosome. |
| List of Excipients |
|---|
|
Benzyl alcohol |
LINCOCIN Injection is available as 5 × 2 mL vials.
Pfizer Australia Pty Ltd, 38-42 Wharf Road, West Ryde NSW 2114, Toll Free Number: 1800 675 229, www.pfizer.com.au
2 August 1991
| Drug | Countries | |
|---|---|---|
| LINCOCIN | Australia, Ecuador, Spain, Japan, Lithuania, Mexico, Poland, Singapore, Turkey |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
